Library
PubMed Central Open Access
research article
Professional
Open access

Cervical Anastomotic Leakage After Minimally InvasiveEsophagectomy in theSurgical System: Clinical Course and Predictors of Delayed Healing

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

Thoracic CancerLast synced 6/12/2026Status: syncedPMID: 42267628 pmidDOI: 10.1111/1759-7714.70314

ABSTRACT Background Cervical anastomotic leakage (AL) remains a major complication after esophagectomy. We investigated the clinical course of cervical AL after minimally invasive McKeown esophagectomy within the SAFER surgical system and identified predictors of delayed healing. tca70314-sec-0001 Methods This retrospective study included 517 consecutive patients who underwent minimally invasive McKeown esophagectomy with retrosternal reconstruction under SAFER between January 2023 and December 2025. Among them, 50 developed cervical AL. A posterior mediastinal comparator cohort of 37 patients with cervical AL was included for comparison of leak severity and healing outcomes. AL severity was assessed using ECCG and Clavien‐Dindo classifications. Cox regression was used to identify predictors of time to closure. tca70314-sec-0002 Results In SAFER group, cervical AL occurred in 50 of 517 patients (9.7%). Compared with the historical same‐surgeon PM leakage cohort, SAFER related leaks showed a lower severity profile, with fewer advanced ECCG events and a less severe Clavien‐Dindo distribution. All SAFER group patients with cervical AL achieved eventual healing, and the median time to closure was shorter in the SAFER group. Low postoperative day 1 serum albumin (< 35 g/L) independently predicted delayed healing. Patients with low albumin had longer healing time and longer postoperative hospitalization. tca70314-sec-0003 Conclusions Within the SAFER surgical system, cervical AL af

Abstract

ABSTRACT Background Cervical anastomotic leakage (AL) remains a major complication after esophagectomy. We investigated the clinical course of cervical AL after minimally invasive McKeown esophagectomy within the SAFER surgical system and identified predictors of delayed healing. tca70314-sec-0001 Methods This retrospective study included 517 consecutive patients who underwent minimally invasive McKeown esophagectomy with retrosternal reconstruction under SAFER between January 2023 and December 2025. Among them, 50 developed cervical AL. A posterior mediastinal comparator cohort of 37 patients with cervical AL was included for comparison of leak severity and healing outcomes. AL severity was assessed using ECCG and Clavien‐Dindo classifications. Cox regression was used to identify predictors of time to closure. tca70314-sec-0002 Results In SAFER group, cervical AL occurred in 50 of 517 patients (9.7%). Compared with the historical same‐surgeon PM leakage cohort, SAFER related leaks showed a lower severity profile, with fewer advanced ECCG events and a less severe Clavien‐Dindo distribution. All SAFER group patients with cervical AL achieved eventual healing, and the median time to closure was shorter in the SAFER group. Low postoperative day 1 serum albumin (< 35 g/L) independently predicted delayed healing. Patients with low albumin had longer healing time and longer postoperative hospitalization. tca70314-sec-0003 Conclusions Within the SAFER surgical system, cervical AL after minimally invasive McKeown esophagectomy was predominantly low grade, manageable, and ultimately healed in all affected patients. Postoperative day 1 serum albumin may help identify patients at risk of prolonged recovery. tca70314-sec-0004 In a 517‐patient cohort, the SAFER surgical system was associated with predominantly low‐grade, manageable cervical anastomotic leakage after minimally invasive McKeown esophagectomy, with no ECCG grade III leakage or leak‐related mortality. POD1 serum albumin helped identify patients at risk of delayed healing. graphical

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.